1. Belgium Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Remedent, Inc.

Remedent, Inc.

REMI
Remedent, Inc.US flagOther OTC
0.00
USD
- -
- -
13,997.00Market Cap
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
TTM
Revenue per Share
0.42
0.75
0.41
0.63
0.48
0.15
0.13
0.18
0.14
0.12
0.14
0.08
0.05
0.06
Basic EPS, GAAP
-0.17
-0.15
-0.12
-0.08
0.02
-0.05
0.03
0.01
0.01
0.04
- -
0.11
-0.04
-0.01
Free Cash Flow per Basic Share
-0.15
-0.08
-0.04
-0.03
-0.03
-0.06
-0.01
- -
-0.02
0.08
- -
0.03
0.01
0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.8
-0.88
-0.98
-1.05
-1.03
-1.08
-1.05
-1.05
-1.04
-1
-1
-0.89
-0.93
-0.92
Tangible Book Value per Share
0.2
0.32
0.15
0.11
0.1
0.07
0.11
0.1
0.11
0.16
0.17
0.27
0.23
0.23
Basic Weighted Avg Shares
18
20
20
20
20
20
20
20
20
20
20
20
20
20
Sales/Revenue/Turnover
7
15
8
13
10
3
3
4
3
2
3
2
1
1
Operating Margin (%)
-41.05
-6.46
-35.75
1.84
-5.19
-61.75
-28.44
2.91
0.26
-45.41
-11.14
-44.73
-45.06
-9.45
Depreciation Expense
- -
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-3
-2
-2
- -
-1
1
- -
- -
1
- -
2
-1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
19.53
- -
- -
18.63
11.48
- -
- -
0.04
- -
2.38
Profit Margin (%)
-41.64
-20.17
-28.49
-12.3
5.06
-33.43
20.23
2.91
5.8
35.84
-2.02
132.74
-80.63
-22.98
Working Capital
2
4
1
1
- -
-1
- -
-1
-1
- -
- -
-2
-2
-2
LT Debt
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
4
6
4
3
2
1
2
2
2
3
3
5
5
5
Return on Invested Capital (%)
- -
- -
- -
- -
-7.15
- -
-15.58
1.9
0.14
- -
- -
-16.09
- -
- -
Return on Capital (%)
- -
- -
- -
- -
0.03
- -
-3.55
-0.74
-1.08
- -
- -
-11.47
- -
2.42
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'21
Sep'21
Dec'21
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
4
3
3

Working Capital

FRC

•

in mil. unless spec.
Jun'21
Sep'21
Dec'21
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
3
3
3
Payables & Accruals
3
3
3
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.64%
20.34%
-15.4%
Free Cash Flow
191%
411.19%
-82.11%
Net Income, GAAP
-446.77%
-753.66%
-140.31%
Sales/Revenue/Turnover
-11.04%
-19.6%
-33.63%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
2
2020
- -
- -
- -
- -
1
2021
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
-0.01
- -
-0.01
- -
0.11
2020
-0.01
-0.01
-0.01
- -
-0.04
2021
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Guy De Vreese
Full Time Employees
3
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
Zuiderlaan 1-3 Gent VL Belgium 9000
IPO Date
Mar 1, 2006
CIK
0001078037
Website
remedent.com
Similar Companies
EssilorLuxottica S.A. (ESLOF)
Golden Valley Development, Inc (GVDI)
AddLife AB (publ) (ADDLF)
Zhonghong Pulin Medical Products Co., Ltd. (300981.SZ)
Tofflon Science and Technology Group Co., Ltd. (300171.SZ)
Imeik Technology Development Co.,Ltd. (300896.SZ)
Business
Remedent Inc researches, designs, develops, manufactures and distributes oral care and cosmetic dentistry products in the United States and internationally. The company primarily provides professional veneers including River8 prefab veneers that enable dentists to customize tooth combinations with minor reshaping, GlamSmile ultra-thin veneers attached to the front of patients' teeth; teeth whitening products for professional and over-the-counter use; SmileMe Mirror for rapid 10-minute smile consultations in dental practices, SmileSketch simulation software for patient visualization, various Treatment Pages explaining treatment benefits; Condor intra-oral 3D scanner; and dental implant solutions and treatment concepts, which it sells through its internal sales force and third-party distributors to dental professionals and consumers. Remedent Inc was incorporated in 1986 and is headquartered in Ghent, Belgium.

Company News

APIChatGPT

  • defenseworld.net

    Reviewing Remedent (OTCMKTS:REMI) & Becton, Dickinson and Company (NYSE:BDX)

  • defenseworld.net

    Reviewing Remedent (OTCMKTS:REMI) and Escalon Medical (OTCMKTS:ESMC)

  • defenseworld.net

    Remedent (OTCMKTS:REMI) vs. Cooper Companies (NASDAQ:COO) Financial Analysis